Bcs Wealth Management Johnson & Johnson Transaction History

Bcs Wealth Management

$235 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 10, 2024	SELL	$155.22 - $162.74 $69,693 - $73,070	-449 Reduced 10.07%	4,010 $634,000
Q4 2023 Jan 11, 2024	BUY	$145.6 - $158.88 $64,209 - $70,066	441 Added 10.98%	4,459 $699,000
Q3 2023 Oct 12, 2023	BUY	$155.75 - $174.48 $625,803 - $701,060	4,018 New	4,018 $626,000
Q1 2023 Apr 10, 2023	SELL	$151.05 - $180.26 $361,311 - $431,181	-2,392 Reduced 53.79%	2,055 $318,000
Q4 2022 Jan 10, 2023	SELL	$160.2 - $179.79 $8,009 - $8,989	-50 Reduced 1.11%	4,447 $786,000
Q3 2022 Oct 07, 2022	SELL	$161.33 - $179.52 $356,216 - $396,380	-2,208 Reduced 32.93%	4,497 $735,000
Q2 2022 Jul 29, 2022	BUY	$168.19 - $186.01 $286,595 - $316,961	1,704 Added 34.07%	6,705 $1.19 Million
Q1 2022 Apr 28, 2022	SELL	$158.14 - $179.59 $437,731 - $497,105	-2,768 Reduced 35.63%	5,001 $886,000
Q4 2021 Jan 18, 2022	BUY	$155.93 - $173.01 $444,088 - $492,732	2,848 Added 57.87%	7,769 $1.33 Million
Q3 2021 Oct 25, 2021	BUY	$161.5 - $179.47 $51,034 - $56,712	316 Added 6.86%	4,921 $795,000
Q2 2021 Jul 21, 2021	BUY	$159.48 - $171.07 $83,567 - $89,640	524 Added 12.84%	4,605 $759,000
Q1 2021 Apr 28, 2021	SELL	$153.07 - $170.48 $6,888 - $7,671	-45 Reduced 1.09%	4,081 $671,000
Q4 2020 Jan 21, 2021	SELL	$137.11 - $157.38 $17,687 - $20,302	-129 Reduced 3.03%	4,126 $649,000
Q3 2020 Oct 23, 2020	BUY	$140.38 - $153.83 $7,019 - $7,691	50 Added 1.19%	4,255 $633,000
Q2 2020 Jul 21, 2020	SELL	$128.81 - $155.51 $9,016 - $10,885	-70 Reduced 1.64%	4,205 $591,000
Q1 2020 Apr 10, 2020	SELL	$111.14 - $153.99 $17,893 - $24,792	-161 Reduced 3.63%	4,275 $561,000
Q4 2019 Feb 10, 2020	BUY	$127.5 - $146.44 $565,590 - $649,607	4,436 New	4,436 $647,000

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bcs Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Bcs Wealth Management with notifications on news.

Account